FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:739 August 19, 2004 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Perspective by Steinbrook, R. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The international AIDS conference highlighted the substantial progress that Thailand has made in reducing the frequency of mother-to-child transmission of HIV and providing antiretroviral treatment. Now, Krisana Kraisintu, the Thai pharmaceutical chemist who helped to spearhead her nation's response to AIDS, has embarked on a self-assigned mission — to bring affordable antiretroviral treatment to three African countries.

Kraisintu is the former director of the Research and Development Institute of the Government Pharmaceutical Organization (GPO) in Thailand and a pioneer in the production of generic antiretroviral medications. In 1995, she brought antiretroviral treatment to Thailand by producing zidovudine to protect newborns . . . [Full Text of this Article]

This article has been cited by other articles:

• Stebbing, J., Mazhar, D., Lewis, R., Palmieri, C., Hatzimichael, E., Nelson, M., Gazzard, B., Bower, M. (2006). The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma. Ann Oncol 17: 503-506 [Abstract] [Full Text]